Waverley Pharma Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CAD 1.375 million compared to CAD 1.157 million a year ago. Net loss was CAD 705,763 compared to CAD 1.214 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.